Postmarket Study of JUVÉDERM VOLBELLA™ With Lidocaine in the Lips

Allergan

Status: Completed

Conditions: Lip Augmentation

Treatments: Device: Crosslinked hyaluronic acid gel

Study type: Observational

Funder types: Industry

Identifiers

NCT01629134

MAF/AGN/MED/FIL/019

Details and patient eligibility

About

A prospective, multicenter postmarket study of the use of JUVÉDERM VOLBELLA™ with Lidocaine in the lips.

Enrollment: 62 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Desire and willingness for correction of asymmetry or volume enhancement of his/her lips
• Females and males ≥ 18 years of age
• Have established a realistic treatment goal that the Physician agrees is achievable, i.e., have realistic expectations of aesthetic results

Exclusion criteria

• Not fulfilling the standard prescribing criteria for JUVÉDERM VOLBELLA™ with Lidocaine as detailed in the Directions for Use
• Have a condition or be in a situation that, in the Physician's opinion, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study

Trial design

62 participants in 1 patient group

Volbella

Description:

Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use

Treatment:

Device: Crosslinked hyaluronic acid gel